A method for non-targeted screening of hydroxy-esterified glucocorticoids in cosmetics using low-resolution mass spectrometry
Through low-resolution mass spectrometry technology and high-performance liquid chromatography-tandem triple quadrupole mass spectrometry, non-targeted screening of hydroxyester-derived glucocorticoids in cosmetics was achieved, which solved the problems of low efficiency and high cost of existing detection methods, reduced the risk of missed detection, and is suitable for the detection of a variety of new hormones.
Patent Information
- Application Number
- CN202511000641.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-21
- Publication Date
- 2025-09-30
- Estimated Expiration
- 2045-07-21
AI Technical Summary
Existing methods for detecting glucocorticoids in cosmetics mainly rely on targeted detection, which has the disadvantages of low detection efficiency, high cost and risk of missed detection. In particular, it is unable to effectively screen new hydroxy-esterified glucocorticoids and cannot meet regulatory requirements.
Low-resolution mass spectrometry technology is used to add sodium hydroxide and stabilizers to the cosmetic sample solution, and the reaction conditions are controlled to allow the hydroxy-esterified glucocorticoids to be directionally hydrolyzed into non-esterified forms. Non-targeted screening is performed in combination with high-performance liquid chromatography-tandem triple quadrupole mass spectrometry, and the qualitative and quantitative analysis of multiple glucocorticoids is achieved by MRM spectral comparison.
It has achieved efficient and low-cost screening of various hydroxy-esterified glucocorticoids, reduced the missed detection rate, expanded the detection range, simplified the operation process, and is suitable for non-targeted detection of various new hormones.